PMV Pharmaceuticals Investor Webinar to Review Phase 2 PYNNACLE Interim Data Evaluating Rezatapopt in Patients with Advanced Solid Tumors
About The Event
Join PMV Pharmaceuticals for an investor webinar to review the interim PYNNACLE Phase 2 data and provide a regulatory update. The event will feature presentations by PMV management and Ramez N. Eskander, M.D., Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego.
KOL BIOGRAPHY
Ramez Eskander, M.D., is a gynecologic oncologist specializing in the surgical management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar, and vaginal cancer. He is the Clinical Trials Office Director for Oncology at Moores Cancer Center and a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego School of Medicine. Dr. Eskander’s research focuses on immunotherapy, targeted therapies, and quality of life in cancer patients. He has co-authored multiple peer-reviewed articles, several book chapters, and received the Society of Gynecologic Oncology's John L. Lewis Jr. Presidential Award. Prior to joining UC San Diego Health, Dr. Eskander was an Assistant Professor in the Department of Obstetrics and Gynecology at UC Irvine School of Medicine, also caring for patients with gynecologic cancer at UC Irvine Medical Center. Dr. Eskander completed a fellowship in gynecologic oncology at UC Irvine School of Medicine and a residency in obstetrics and gynecology at UC San Diego School of Medicine, where he also earned his medical degree.
